SEPTIN9 and breast carcinoma: SEPT9, in particular SEPT9_i1, has been linked to many cancers of bad prognosis, to cell resistance to MTA and was found to be overexpressed during the interphase (G1 and S) in breast cancer (Gonzalez et al., 2009).